Market Tracker

04/29 5:51am ET

Seattle Genetics Inc (NASDAQ:SGEN)

37.29
Delayed Data
As of Apr 28
 -0.78 / -2.05%
Today’s Change
26.02
Today|||52-Week Range
52.33
-16.91%
Year-to-Date

Today’s Trading

Previous close38.07
Today’s open37.67
Day’s range36.93 - 38.69
Volume1,060,875
Average volume (3 months)1,233,377
Market cap$5.3B
Dividend yield--
Data as of 04/28/2016

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)-9.04%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+17.45%
P/E ratioNM
Price/Sales17.21
Price/Book7.75

Competitors

 Today’s
change
Today’s
% change
UTHRUnited Therapeutics ...-12.84-10.91%
OPKOPKO Health Inc-0.05-0.46%
TAROTaro Pharmaceutical ...+0.26+0.19%
ALKSAlkermes Plc+0.72+1.77%
Data as of 04/28/2016

Financials

Last reporting dateApril 29, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$336.8M
Annual profit (last year)-$120.5M
Net profit margin-35.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
Chief Operating Officer
Eric L. Dobmeier
Corporate headquarters
Bothell, Washington

Forecasts